Work

948P Predicting the efficacy of lenvatinib plus anti-PD-1 antibodies in unresectable hepatocellular carcinoma (uHCC) using radiomics features of tumors extracted from baseline MRI

Year: 2021

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.168

Authors: H. Sun, S-X. Rao, B. Xu, X-D. Zhu, S-Y. Dong, X-L. Li, C. Huang, Y-H. Shen, J-J. Zhu, M-L. Li, J. Liu, M-S. Zeng, J. Zhou, J. Fan

Institutions: Fudan University, Zhongshan Hospital, Shanghai Medical College of Fudan University

Language: English

Topic: Radiomics and Machine Learning in Medical Imaging

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Fudan University, Ipsen, Sirtex Medical

OpenAlex ID: W3202056022

FWCI:

Cites:

Cited by: 1

Related to: 10